Please use this identifier to cite or link to this item: http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3533
Full metadata record
DC FieldValueLanguage
dc.creatorCampo, Rosa Del-
dc.creatorTenorio, Carmen-
dc.creatorJiménez Díaz, Rufino-
dc.creatorRubio, Carmen-
dc.creatorGómez-Lus, Rafael-
dc.creatorBaquero, Fernando-
dc.creatorTorres, Carmen-
dc.date2008-04-11T07:19:18Z-
dc.date2008-04-11T07:19:18Z-
dc.date2001-03-
dc.date.accessioned2017-01-31T01:01:59Z-
dc.date.available2017-01-31T01:01:59Z-
dc.identifierAntimicrobial Agents and Chemotherapy 45(3): 905–912 (2001)-
dc.identifier1098-6596-
dc.identifierhttp://hdl.handle.net/10261/3533-
dc.identifier10.1128/AAC.45.3.905-912.2001-
dc.identifier.urihttp://dspace.mediu.edu.my:8181/xmlui/handle/10261/3533-
dc.descriptionBacteriocin production was determined for 218 Enterococcus isolates (Enterococcus faecalis [93] and E. faecium [125]) obtained from different origins (human clinical samples [87], human fecal samples [78], sewage [28], and chicken samples [25]) and showing different vancomycin susceptibility patterns (vancomycin resistant, all of them vanA positive [56], and vancomycin susceptible [162]). All enterococcal isolates were randomly selected except for the vancomycin-resistant ones. A total of 33 isolates of eight different bacterial genera were used as indicators for bacteriocin production. Forty-seven percent of the analyzed enterococcal isolates were bacteriocin producers (80.6% of E. faecalis and 21.6% of E. faecium isolates). The percentage of bacteriocin producers was higher among human clinical isolates (63.2%, 81.8% of vancomycin-resistant isolates and 60.5% of vancomycin-susceptible ones) than among isolates from the other origins (28 to 39.3%). Only one out of the 15 vancomycin-resistant isolates from human fecal samples was a bacteriocin producer, while 44.4% of fecal vancomycin-susceptible isolates were. The bacteriocin produced by the vanA-containing E. faecium strain RC714, named bacteriocin RC714, was further characterized. This bacteriocin activity was cotransferred together with the vanA genetic determinant to E. faecalis strain JH2-2. Bacteriocin RC714 was purified to homogeneity and its primary structure was determined by amino acid sequencing, showing an identity of 88% and a similarity of 92% with the previously described bacteriocin 31 from E. faecalis YI717. The presence of five different amino acids in bacteriocin RC714 suggest that this could be a new bacteriocin. The results obtained suggest that the epidemiology of vancomycin resistance may be influenced by different factors, including bacteriocin production.-
dc.descriptionR. D. C. was supported by a grant from the Diputación General de Aragón of Spain (project P49/97) and from the Sociedad Española de Quimioterapia. This work has been supported in part by a grant from the Fondo de Investigaciones Sanitarias (00/0545) of Spain.-
dc.descriptionPeer reviewed-
dc.format320677 bytes-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherAmerican Society for Microbiology-
dc.rightsclosedAccess-
dc.titleBacteriocin Production in Vancomycin-Resistant and Vancomycin-Susceptible Enterococcus Isolates of Different Origins-
dc.typeArtículo-
Appears in Collections:Digital Csic

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.